Finance

Beta
Lists
VSTM:NASDAQ
Verastem Inc
$3.78
+9.57%
(+0.33) 1D
$3.75
-0.79% (-0.030)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VSTM...
Open
$3.50
High
$3.82
Low
$3.44
Mkt. cap
332.16M
Avg. vol.
2.43M
Volume
8.03M
52-wk high
$11.24
52-wk low
$3.43
EPS
-$2.50
Beta
0.27
Shares outstanding
87.87M
No. of employees
102
Open
$3.50
High
$3.82
Low
$3.44
Mkt. cap
332.16M
Avg. vol.
2.43M
Volume
8.03M
52-wk high
$11.24
52-wk low
$3.43
EPS
-$2.50
Beta
0.27
Shares outstanding
87.87M
No. of employees
102
News stories
From sources across the web
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com
Analyst ratings
Based on 8 analysts giving stock ratings to VSTM in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for VSTM in the last 3 months.
Highest
Current $3.78
$18.00 (+376.19%)
Average
$15.13 (+300.26%)
Lowest
$8.00 (+111.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$14.00
+270.4%
06/25/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
$18.00
+376.2%
06/24/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$18.00
+376.2%
06/24/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
$15.00
+296.8%
06/23/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
$18.00
+376.2%
06/24/2026
Faisal Khurshid
Jefferies
Buy
Maintained
$8.00
+111.6%
06/23/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
$16.00
+323.3%
05/22/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$14.00
+270.4%
05/07/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$18.00
+376.2%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.14M
11.24M
17.54M
18.67M
Cost of goods sold
318.00K
1.67M
2.61M
2.77M
Cost of revenue
318.00K
1.67M
2.61M
2.77M
Research and development expenses
24.79M
28.99M
31.67M
37.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.67M
21.01M
24.44M
22.54M
Operating expense
45.58M
50.29M
56.40M
60.80M
Total operating expenses
45.90M
51.96M
59.01M
63.57M
Operating income
-43.76M
-40.72M
-41.48M
-44.90M
Other non operating income
17.22M
-58.67M
7.87M
7.39M
EBT including unusual items
-25.93M
-98.52M
-32.92M
-36.59M
EBT excluding unusual items
-25.93M
-98.52M
-32.92M
-36.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-25.93M
-98.52M
-32.92M
-36.59M
Net profit margin
-1,213.57%
-876.34%
-187.72%
-195.98%
Earnings per share
-0.63
-0.54
-0.46
-0.43
Interest and investment income
822.00K
1.18M
1.10M
1.30M
Interest expense
-212.00K
-319.00K
-415.00K
-382.00K
Net interest expenses
610.00K
863.00K
689.00K
915.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.64M
-40.42M
-41.18M
-44.62M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VSTM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer